Promega™ Recombinant RNasin™ Ribonuclease Inhibitor
Ideal for any application where eukaryotic RNase contamination is a potential problem
Manufacturer: promega™ N2511
U.S. Patents 4,966,964, 5,019,556, and 5,266,687; Australian Patents 616881 and 641261, are exclusively licensed to Promega Corporation.
U.S. Patent 5,552,302, Australian Patent 646803.
|Storage Requirements||Store at -20°C.|
|For Use With (Application)||RT-PCR, protection of mRNA in cDNA synthesis reactions, in-vitro transcription/translation, Increase yield and activity of polysomes, improvement of in-vitro virus replication, improvement of RNA translation in homologous systems|
|Concentration||20 to 40U/μL|
Get Up to $1,000 in Complimentary Promega Products
Purchase up to $1,000 in any combination of Promega™ reagents and receive an equivalent amount of complimentary Promega products of your choice. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.Buy Now